pretty amazing research…. “Here, we confirmed cancer cell recognition by a T cell clone that responded to multiple cancer cell lines from diverse tissue types, resulting in killing of cancer cells in vitro and in vivo.” https://t.co/4FcnPJjDuC
RT @RMirnezami: This is huge! https://t.co/5hi3yVHrLP
"Opportunity for HLA-independent, pan-cancer, pan-population immunotherapies" https://t.co/J25Mfjbcpi
RT @alanlparker: Congratulations @TcellResearch on this fantastic piece of work, published today in @NatImmunol - delighted to play a small…
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/tMFBOYR9JM
It is an interesting finding but imo irresponsible to talk about a "one-size-fits-all cancer treatment" https://t.co/x9tBUEkeR0 https://t.co/IQiT2kGOb2
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
If it binds, we can kill it "we use genome-wide CRISPR–Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human cancer types via the monomorphic MHC class I-related protein, MR1, while remaining inert to noncancerous cells"
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
A (non-MAIT) MR1 restricted anti-cancer T cell clone, even when MR1 not detectable by Ab. Very cool!
RT @RossjohnLab: https://t.co/b0yWHH6cdE Great work by the Sewell lab @TcellResearch @CUSystemsImmu
RT @Dr_Sri_Ram: Fascinating work. ...’a T cell receptor (TCR) recognized and killed most human cancer types via the monomorphic MHC class I…
Fascinating work. ...’a T cell receptor (TCR) recognized and killed most human cancer types via the monomorphic MHC class I-related protein, MR1, while remaining inert to noncancerous cells’
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
Exciting or what!? https://t.co/4RzxwMgOkm
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/uLTBbJltU5
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/rjqShEbbAh https://t.co/0mnWIf89mN
Did you know scientists recently found the “Achilles Hill” found in many types of cancer? It’s called MR1. They can program and clone a T-cell to “seek and destroy” cancer cells labeled with MR1. The great thing is MR1 is not found on non-cancerous cells.
This is huge! https://t.co/5hi3yVHrLP
RT @Demostenes_eu: Wow 😯
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
Wow 😯
RT @horowitz_b: אני חושב שכאן ראוי שרשור קצר על מה ולמה. לדעתי זה מרגש מאוד. העבודה הזו בשלבים *מאוד* ראשוניים ולא נוסתה בבני אדם עדיין, אב…
RT @bidatzi: BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic…
BOOM, this one's a home run: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/r9KeaxGmug Goddamnit, yes! we're on our way to universal cancer targeting through t
RT @horowitz_b: אני חושב שכאן ראוי שרשור קצר על מה ולמה. לדעתי זה מרגש מאוד. העבודה הזו בשלבים *מאוד* ראשוניים ולא נוסתה בבני אדם עדיין, אב…
Genome-wide #CRISPR–Cas9 screening reveals ubiquitous T cell #cancer targeting via the monomorphic MHC class I-related protein MR1. https://t.co/umjgCuHysn
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
Our very own T-cell modulation group all over @BBCNews today for their work on T cell to target multiple cancers! @britsocimm #Immunology #immunotherapy
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology https://t.co/laWHWtuPZY
RT @horowitz_b: אני חושב שכאן ראוי שרשור קצר על מה ולמה. לדעתי זה מרגש מאוד. העבודה הזו בשלבים *מאוד* ראשוניים ולא נוסתה בבני אדם עדיין, אב…
A radical new one-size-fits-all approach to cancer? https://t.co/MVeejHFoHr Must read in @NatImmunol #oncology #cancer #immunotherapy
BBC News - Immune discovery 'may treat all cancer' https://t.co/AMuQlL0FV3 The paper: https://t.co/yCqOEjoYhQ @BBCNews @nature #cancer #CRISPR
RT @KingOfPathogens: Not your usual MAIT. Anti-tumor T cells that recognize class I like molecule MR1 can kill many tumor cells types indep…
RT @RossjohnLab: https://t.co/b0yWHH6cdE Great work by the Sewell lab @TcellResearch @CUSystemsImmu
אני חושב שכאן ראוי שרשור קצר על מה ולמה. לדעתי זה מרגש מאוד. העבודה הזו בשלבים *מאוד* ראשוניים ולא נוסתה בבני אדם עדיין, אבל אם הם יצליחו, השיטה הזו תוכל לטפל ברוב סוגי הסרטן בבני אדם. >
יש לי גישה רק לאבסטרקט אבל זה נראה מאמר מדהים. אם זה יעבוד, זה אפילו יותר מטורף מ-CAR-T. זה יכול להיות הנובל הבא (יותר נכון, בעתיד מתישהו). https://t.co/tzEHOsR1lb
Is a more “universal” T cell therapy for cancer within reach? Exciting (although still much to reveal) findings in this publication today! https://t.co/YZuBjinj4H #cancer #immunotherapy #tcell
#Immu | #Feedly Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 https://t.co/9kQx9Czy8w
Not your usual MAIT. Anti-tumor T cells that recognize class I like molecule MR1 can kill many tumor cells types independent of class I. May be sensing cancer cell metabolites? https://t.co/IA39ZJsfwJ
RT @alanlparker: Congratulations @TcellResearch on this fantastic piece of work, published today in @NatImmunol - delighted to play a small…
RT @curexcomplex: After having to do my own legwork since the BBC article didn't correctly link to the paper, here is the actual paper: htt…
After having to do my own legwork since the BBC article didn't correctly link to the paper, here is the actual paper: https://t.co/D13UAFD6EA Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-relat
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
@BBCScienceNews Crowther, M.D., Dolton, G., Legut, M. et al. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. Nat Immunol (2020) doi:10.1038/s41590-019-0578-8 https://t.co/4oA
@perrymetzger https://t.co/iBlgH36vSE @JamesTGallagher would it really be so hard to link directly to the research?
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
Really proud of this new paper being published in Nature Immunology! Check it out! https://t.co/XIM3muaEyI @TcellResearch
RT @TcellResearch: Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m
Congratulations @TcellResearch on this fantastic piece of work, published today in @NatImmunol - delighted to play a small part in this important research. https://t.co/Gj7OuCd7q7
Here's the link to that new paper, published today in Nature Immunology. https://t.co/sV65aofo8m